BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35022380)

  • 21. Systematic prediction of key genes for ovarian cancer by co-expression network analysis.
    Wang M; Wang J; Liu J; Zhu L; Ma H; Zou J; Wu W; Wang K
    J Cell Mol Med; 2020 Jun; 24(11):6298-6307. PubMed ID: 32319226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
    Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weighted gene co-expression network analysis revealed key biomarkers associated with the diagnosis of hypertrophic cardiomyopathy.
    Li X; Wang C; Zhang X; Liu J; Wang Y; Li C; Guo D
    Hereditas; 2020 Oct; 157(1):42. PubMed ID: 33099311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic identification of key functional modules and genes in esophageal cancer.
    Wu R; Zhuang H; Mei YK; Sun JY; Dong T; Zhao LL; Fan ZN; Liu L
    Cancer Cell Int; 2021 Feb; 21(1):134. PubMed ID: 33632229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy-related biomarkers in preeclampsia: the underlying mechanism, correlation to the immune microenvironment and drug screening.
    Wan R; Yao P; Wang Y; Zhang L; Guo W; Du M; Wang Y; Shi W; Li W
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):1. PubMed ID: 38166707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of cervical cancer-related hub genes based on comprehensive bioinformatics analysis.
    Tu S; Zhang H; Yang X; Wen W; Song K; Yu X; Qu X
    Cancer Biomark; 2021; 32(3):303-315. PubMed ID: 34151839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Five-Gene Expression Signature Predicts Ovarian Cancer Metastasis.
    Gu Y; Zhang S
    Crit Rev Eukaryot Gene Expr; 2021; 31(5):41-50. PubMed ID: 34591389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Weighted Gene Coexpression Network Analysis to Identify Key Modules and Hub Genes in Systemic Juvenile Idiopathic Arthritis.
    Zhou M; Guo R; Wang YF; Yang W; Li R; Lu L
    Biomed Res Int; 2021; 2021():9957569. PubMed ID: 34435051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico.
    Chen J; Cai Y; Xu R; Pan J; Zhou J; Mei J
    Cancer Cell Int; 2020; 20():270. PubMed ID: 32595417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Hub Biomarkers and Immune-Related Pathways Participating in the Progression of Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Xia MD; Yu RR; Chen DM
    Front Immunol; 2021; 12():809325. PubMed ID: 35069594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of core genes in ovarian cancer by an integrative meta-analysis.
    Li W; Liu Z; Liang B; Chen S; Zhang X; Tong X; Lou W; Le L; Tang X; Fu F
    J Ovarian Res; 2018 Nov; 11(1):94. PubMed ID: 30453999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of Hub Genes for Ovarian Cancer Stem Cell Properties with Weighted Gene Co-expression Network Analysis].
    Luo M; Zeng H; Ma XY; Ma XL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):248-258. PubMed ID: 33829699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-expression modules construction by WGCNA and identify potential hub genes and regulation pathways of postpartum depression.
    Deng Z; Cai W; Liu J; Deng A; Yang Y; Tu J; Yuan C; Xiao H; Gao W
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1019-1030. PubMed ID: 34856750
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma.
    Ge Y; Li W; Ni Q; He Y; Chu J; Wei P
    Med Sci Monit; 2019 Sep; 25():7272-7288. PubMed ID: 31562292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
    Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
    Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.